| Target Price | HK$24.79 |
| Price | HK$15.20 |
| Potential | |
| Number of Estimates | 4 |
| 4 Analysts have issued a price target Consun Pharmaceutical Group 2027 . The average Consun Pharmaceutical Group target price is HK$24.79. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 8 analysts: 7 Analysts recommend Consun Pharmaceutical Group to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Consun Pharmaceutical Group stock has an average upside potential 2027 of . Most analysts recommend the Consun Pharmaceutical Group stock at Purchase. |
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
4 Analysts have issued a sales forecast Consun Pharmaceutical Group 2026 . The average Consun Pharmaceutical Group sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
4 Consun Pharmaceutical Group Analysts have issued a net profit forecast 2026. The average Consun Pharmaceutical Group net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
4 Analysts have issued a Consun Pharmaceutical Group forecast for earnings per share. The average Consun Pharmaceutical Group EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Consun Pharmaceutical Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


